Working… Menu

Self-Propelled Versus Standard Percutaneous Endoscopic Gastrojejunostomy(PEG-J); RCT

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01892267
Recruitment Status : Terminated (Study was terminated prematurely as costs incurred were more than the available funds.)
First Posted : July 4, 2013
Results First Posted : May 17, 2017
Last Update Posted : May 17, 2017
Information provided by (Responsible Party):
Mouen Khashab, Johns Hopkins University

Brief Summary:
Our main hypothesis is that self-propelled Percutaneous Endoscopic Gastrojejunostomy tube (PEG-J) that has a balloon on it's tip is associated with lower J-tube retrograde migration rate, and lower rates of short- and long-term complications when compared to standard PEGJ feeding tubes.

Condition or disease Intervention/treatment Phase
Feeding Tube Device: PEG-J placement Phase 2

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 19 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Participant)
Primary Purpose: Supportive Care
Official Title: Comparison Outcomes and Complications of Self-Propelled vs. Standard Percutaneous Endoscopic Gastrojejunostomy (PEG-J); a Randomized Single Blind Clinical Trial
Actual Study Start Date : September 6, 2013
Actual Primary Completion Date : December 2014
Actual Study Completion Date : December 2014

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Endoscopy

Arm Intervention/treatment
Experimental: Self-propelled PEGJ feeding tube
Patients in this arm will receive self-propelled balloon PEGJ tube.
Device: PEG-J placement
PEG-J placement

Active Comparator: Standard PEGJ feeding tube
Patients in this arm will receive the standard commercially availabel PEGJ tube.
Device: PEG-J placement
PEG-J placement

Primary Outcome Measures :
  1. Number of Participants With PEG-J Tube Migration [ Time Frame: From date of placement up to 4 weeks ]
    Number of participants in whom migration was assessed by X-ray at 4 weeks post-intervention.

Secondary Outcome Measures :
  1. Repeat Endoscopy for Feeding Tube Placement Due to Retrograde Tube Migration [ Time Frame: 4 weeks ]
    Patiens who will have retrograde PEG-J tube migration will get repeat endoscopy for PEG-J tube placement

  2. Patency of Feeding Tube [ Time Frame: 2 years ]
    Determine tube patency which is defined as time period between tube placement and need for re-intervention.

  3. Technical Success [ Time Frame: Intra-procedural ]
    Success of tube placement in the desired location as determined endoscopically.

  4. Intervention Time [ Time Frame: Intra-procedural ]
    Time required from introduction of the upper endoscope until placement of the feeding tube.

  5. Time to Repeat Endoscopy for Tube Replacement [ Time Frame: 2 years ]
    If repeate endocopy and tube placement are needed due to clogging or retrograde migration

  6. Difficulty of the Procedure [ Time Frame: Inra-procedural ]

    Scored by the endoscopist on a 10-point Visual Analogue Scale with zero being "without difficulty" and 10 being "maximum difficulty".

    The lower the score, the better the outcome.

  7. Gastrointestinal Quality of Life Index (GIQLI) Score [ Time Frame: 3 month ]
    Gastrointestinal Quality of Life Index (GIQLI) score ranging from 0 (worst quality of life possible with severe digestive symptoms) to 144 (optimal quality of life without symptoms

  8. Short-term Complications [ Time Frame: One week ]
    Short-term complications will include stomal (Infection, erythema, bleeding, pain and secretion, etc) and tube (Clotting, dislocation, defect, aspiration, etc) complications detected in the first week.

  9. Long-term Complications [ Time Frame: 2 years ]
    Long-term complications will include stomal (Infection, erythema, bleeding, pain, secretion, abscess, etc) and tube (Clotting, dislocation, defect and aspiration, etc) complications detected more than one week after intervention.

  10. Direct Cost [ Time Frame: 2 years ]
    Cost will be determined according to Medicare reimbursement of billed CPT codes. The cost of all related follow-up procedures will be included (e.g. cost of standard PEGJ in case of failed Self-propelled PEGJ feeding tube, cost of managing complications, cost of re-intervention in case of tube dysfunction, etc)

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   18 Years to 80 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Consecutive adult patients (18-80 years of age) with need for post-pyloric feeding (patients unable to eat due to stroke, intubated patients with respiratory failure, patients with acute pancreatitis, etc).
  • Ability to give informed consent.

Exclusion Criteria:

  • Unable to give informed consent
  • Pregnant or breastfeeding women (all women of child-bearing age will undergo urine pregnancy testing)
  • Acute gastrointestinal bleeding
  • Coagulopathy defined by prothrombin time < 50% of control; PTT > 50 sec, or INR > 1.5), on chronic anticoagulation, or platelet count <50,000
  • Inability to tolerate sedated upper endoscopy due to cardio-pulmonary instability or other contraindication to endoscopy
  • Cirrhosis with portal hypertension, varices, and/or ascites
  • Allergy to egg

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT01892267

Layout table for location information
United States, Maryland
Johns Hopkins Hospital
Baltimore, Maryland, United States, 21205
Sponsors and Collaborators
Johns Hopkins University
Layout table for investigator information
Principal Investigator: Mouen Khashab, MD Johns Hopkins Hospital Department of Gastroenterology

Layout table for additonal information
Responsible Party: Mouen Khashab, Assistant Professor of Medicine; Director of Therapeutic Endoscopy, Johns Hopkins University Identifier: NCT01892267     History of Changes
Other Study ID Numbers: NA_00079056
First Posted: July 4, 2013    Key Record Dates
Results First Posted: May 17, 2017
Last Update Posted: May 17, 2017
Last Verified: April 2017
Keywords provided by Mouen Khashab, Johns Hopkins University:
Percutaneous Endoscopic Gastrostomy
Feeding tube
Acute pancreatitis
Respiratory failure